Trump Echoing Fascists Doesn’t Dissuade Likely GOP Iowa Caucusgoers
By Heather Digby Parton,
Truthout
| 12. 18. 2023
Donald Trump believes in eugenics. He really does. Of course, his understanding of it is purely based upon his own belief in his superior genes and good “German blood.” He’s said it many times in public:
When he said during his first term that he didn’t understand why the U.S. allowed people from “shit-hole countries” to emigrate to the U.S. and suggested that we should encourage people from Norway to come instead, it wasn’t hard to figure out what he meant by that. His xenophobia never applied to white European immigrants. After all, he married two of them and they are the mothers of four of his five children. His problem is with people of different races.
If someone of a different race expresses devotion to him then of course he likes them. Think of Kim Jong Un, whom he considers to be one of his greatest allies. But it’s a very individual thing. For the most part, Trump believes that people from the “shit-hole” countries are genetically inferior to people like him with his good German blood.
Trump’s...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...